New Drug "Cocktails" Prove Effective Against Hepatitis

Research Also Links New Virus and Unexplained Liver Disease

CHICAGO, November 9 - At The American Association for the Study of Liver Diseases 1998 Annual Meeting in Chicago, November 6 - 10, some of the world's top biomedical researchers unveiled studies of drug therapies that are offering new hope in the fight against Hepatitis B and C. Another study examined the role of a newly discovered virus in liver disease.

HIV Drug Lamivudine Helps Hepatitis B Patients When Interferon Can't

At the AASLD Annual Meeting, Eugene Schiff, MD, University of Miami, discussed a study of the effects of a new drug, Lamivudine, that was given to chronic Hepatitis B patients who had previously failed Interferon therapy. There are many such patients, because Interferon is effective only 30%-40% of the time. Lamivudine, a drug that has been used to treat HIV patients, can be taken orally unlike Interferon, which must be injected every day. The study found that patients who took Lamivudine did much better than those who took a placebo, or who took Lamivudine in combination with Interferon. All those who took the new drug alone depressed the level of Hepatitis B virus in their bodies. Almost three quarters cleared the virus, either permanently or as long as they kept taking the drug "All in all, Lamivudine appears safe and effective," said Schiff. "In the future, I expect it will be used in combination with other drugs as part of an overall treatment of chronic Hepatitis B patients."

Interferon alfa-2b +ribavirin vs. Hepatitis C - Three Studies

Three studies on treatment of chronic Hepatitis C, reported at the AASLD Annual Meeting, found that acombination of Interferon alfa-2b and ribavirin (Rebetol) was dramatically effective. John McHutchison, MD, of Scripps Clinic and Research Foundation, reported on one study of more than 900 chronic Hepatitis C patients who had not had antiviral therapy before. Half the patients were give

Contact: Kirk Monroe
American Association For The Study of Liver Diseases

Page: 1 2 3

Related biology news :

1. Proven method of bone analysis may clarify human origins
2. Researchers Prove Chemoprevention Can Work
3. Drug Combination May Prove Effective To Prevent Recurrence Of Hepatitis C After Transplantation
4. Penn Researchers Prove "Short-Cut" Function Of Myelin Sheath Channel: BetterUnderstanding Of Myelin Should Lead To Therapies For Neuropathies
5. Reengineered Poliovirus Proves Effective As Vector For Prompting Key Immune Response In A Study With Mice
6. Simplified Therapy To Prevent TB Proven Effective In Developing Countries
7. High Levels of Vitamin C Prove Toxic to HIV
8. Effective acne treatments remain elusive, Hopkins researchers find
9. Study Ensures Effective Ways To Measure Macular Pigment Density
10. Discovery Of 13 Genes Expressed In Brain Tumors May Lead To More Effective Diagnosis Or Prevention
11. New Drug Shown Effective Against Vancomycin-Resistant Bacteria

Post Your Comments:

(Date:6/5/2020)... ... ... Greffex, a pioneering vaccine and gene therapy company based in Houston, Texas, welcomes Mr. ... global perspective to make an impact in a post pandemic world,” said Co-Chairman John ... director of the company. , “The Greffex board is excited to have Neil as ...
(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer and manufacturer of biometric ... Group (CEG) to market and sell its complete line of biometric readers and ... infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales ...
(Date:5/28/2020)... and FORT WORTH, Texas (PRWEB) , ... May ... ... stage biopharmaceutical company, announced today that interim results from their 1801 Phase 1/2 ... of Clinical Oncology (ASCO) Annual Meeting which will take place virtually on May ...
Breaking Biology News(10 mins):
(Date:4/7/2020)... ... April 06, 2020 , ... Gateway Genomics , leading developer ... SneakPeek Early Gender DNA Tests sold in March, just months after attaining ... an ecommerce product, where a mom could order her kit online, collect a DNA ...
(Date:4/1/2020)... ... March 30, 2020 , ... Kinetic Vet, an animal ... EPA-approved spray-on antimicrobial solution. As a first-of-its-kind technology within the animal health industry, ... against microorganisms for up to 90 days. , In addition to reducing the ...
(Date:4/1/2020)... , ... March 31, 2020 ... ... Systems, B.V. (MBS) has developed a method using its revolutionary NEXTGENPCR endpoint ... minutes. Combined with smaller reaction volumes, increased samples per run, and standard, ...
(Date:4/1/2020)... ... March 31, 2020 , ... Bedoukian Research, Inc. ... a Joint Development Agreement that builds on each company’s expertise in developing efficient ... in the supply of high-quality insect pheromones as well as flavors and fragrances. ...
Breaking Biology Technology:
Cached News: